LSTA: Lisata Therapeutics, Inc. Stock

by  •  • Comments Off on LSTA: Lisata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 17.49
Enterprise Value ($M) 1.03
Book Value ($M) 29.32
Book Value / Share 3.49
Price / Book 0.60
NCAV ($M) 28.89
NCAV / Share 3.44
Price / NCAV 0.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.68
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.47

Liquidity (mrq)
Quick Ratio 6.16
Current Ratio 6.16

Balance Sheet (mrq) ($M)
Current Assets 34.58
Assets 35.00
Liabilities 5.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.00
Operating Income -22.41
Net Income -19.98
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic And Diluted Since Acquisition n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.36
Cash from Investing 13.23
Cash from Financing -0.21

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 626 5,314 11.78
2025-04-16 713 4,384 16.26
2025-04-15 1,702 17,613 9.66
2025-04-14 38 6,317 0.60

(click for more detail)

Similar Companies
LPCN – Lipocine Inc. LPTX – Leap Therapeutics, Inc.
LQDA – Liquidia Corporation LTRN – Lantern Pharma Inc.
MBIO – Mustang Bio, Inc.


Financial data and stock pages provided by
Fintel.io